Royalty Pharma Stock Forecast - Triple Exponential Smoothing

RPRX Stock  USD 26.60  0.31  1.18%   
The Triple Exponential Smoothing forecasted value of Royalty Pharma Plc on the next trading day is expected to be 26.66 with a mean absolute deviation of 0.22 and the sum of the absolute errors of 12.79. Royalty Stock Forecast is based on your current time horizon.
  
At this time, Royalty Pharma's Inventory Turnover is fairly stable compared to the past year. Receivables Turnover is likely to rise to 3.53 in 2024, whereas Payables Turnover is likely to drop 31.45 in 2024. . Common Stock Shares Outstanding is likely to drop to about 409.1 M in 2024. Net Income Applicable To Common Shares is likely to drop to about 46.8 M in 2024.
Triple exponential smoothing for Royalty Pharma - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Royalty Pharma prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Royalty Pharma price movement. However, neither of these exponential smoothing models address any seasonality of Royalty Pharma Plc.

Royalty Pharma Triple Exponential Smoothing Price Forecast For the 30th of November

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Royalty Pharma Plc on the next trading day is expected to be 26.66 with a mean absolute deviation of 0.22, mean absolute percentage error of 0.08, and the sum of the absolute errors of 12.79.
Please note that although there have been many attempts to predict Royalty Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Royalty Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Royalty Pharma Stock Forecast Pattern

Backtest Royalty PharmaRoyalty Pharma Price PredictionBuy or Sell Advice 

Royalty Pharma Forecasted Value

In the context of forecasting Royalty Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Royalty Pharma's downside and upside margins for the forecasting period are 25.66 and 27.65, respectively. We have considered Royalty Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
26.60
26.66
Expected Value
27.65
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Royalty Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Royalty Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.0443
MADMean absolute deviation0.2168
MAPEMean absolute percentage error0.008
SAESum of the absolute errors12.792
As with simple exponential smoothing, in triple exponential smoothing models past Royalty Pharma observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Royalty Pharma Plc observations.

Predictive Modules for Royalty Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Royalty Pharma Plc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
25.6126.6027.59
Details
Intrinsic
Valuation
LowRealHigh
21.5622.5529.26
Details
Bollinger
Band Projection (param)
LowMiddleHigh
25.3826.3827.37
Details
10 Analysts
Consensus
LowTargetHigh
44.2948.6754.02
Details

Other Forecasting Options for Royalty Pharma

For every potential investor in Royalty, whether a beginner or expert, Royalty Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Royalty Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Royalty. Basic forecasting techniques help filter out the noise by identifying Royalty Pharma's price trends.

View Royalty Pharma Related Equities

 Risk & Return  Correlation

Royalty Pharma Plc Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Royalty Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Royalty Pharma's current price.

Royalty Pharma Market Strength Events

Market strength indicators help investors to evaluate how Royalty Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Royalty Pharma shares will generate the highest return on investment. By undertsting and applying Royalty Pharma stock market strength indicators, traders can identify Royalty Pharma Plc entry and exit signals to maximize returns.

Royalty Pharma Risk Indicators

The analysis of Royalty Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Royalty Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting royalty stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Royalty Stock Analysis

When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.